Dana-farber Cancer Insitiute — Boston, Massachusetts

Dana-farber Cancer Insitiute is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Dana-farber Cancer Insitiute has participated in 1 clinical trials.

Therapeutic areas: Lymphoplasmacytic Lymphoma, Waldenstrom's Macroglobulinemia.

Sponsors: Dana-Farber Cancer Institute.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-farber Cancer Insitiute?

Dana-farber Cancer Insitiute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-farber Cancer Insitiute conducted?

Dana-farber Cancer Insitiute has 1 clinical trials on record. Their work covers Lymphoplasmacytic Lymphoma, Waldenstrom's Macroglobulinemia.

Is Dana-farber Cancer Insitiute accredited by Crixeo Health?

Dana-farber Cancer Insitiute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-farber Cancer Insitiute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.